Mymetics Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MYMX research report →
Companywww.mymetics.com
Mymetics Corporation, a vaccine company, engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines.
- CEO
- Ronald Kempers
- IPO
- 1999
- Employees
- 2
- HQ
- Epalinges, CH
Price Chart
Valuation
- Market Cap
- $46
- P/E
- -0.02
- P/S
- 0.01
- P/B
- -0.00
- EV/EBITDA
- -36.02
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -47966.67%
- Op Margin
- -58166.67%
- Net Margin
- -160166.67%
- ROE
- 7.69%
- ROIC
- -24.57%
Growth & Income
- Revenue
- $3.00K · 0.00%
- Net Income
- $-4,805,000 · -1.59%
- EPS
- $-0.02 · 32.77%
- Op Income
- $-1,745,000
- FCF YoY
- 1.11%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 2.13
- Avg Volume
- 1
Get TickerSpark's AI analysis on MYMX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 9, 15 | KEMPERS Ronald Hugo Gerard | other | 5,000,000 |
| Jan 31, 06 | Round Enterprises, Ltd. | other | 0 |
| Jan 31, 06 | Round Enterprises, Ltd. | other | 0 |
| Oct 4, 13 | Fleury Sylvain | other | 800,000 |
| Dec 31, 09 | Fleury Sylvain | other | 350,000 |
| Jun 18, 07 | Fleury Sylvain | other | 0 |
| Jun 17, 10 | Stegmann Antonius Johannes | other | 4,000,000 |
| Jun 17, 10 | Stegmann Antonius Johannes | other | 150,000 |
| Dec 27, 13 | KEMPERS Ronald Hugo Gerard | sell | 3,000,000 |
| Dec 27, 13 | KEMPERS Ronald Hugo Gerard | other | 3,000,000 |
Our MYMX Coverage
We haven't published any research on MYMX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MYMX Report →